Drug Approval | September 08, 2025
USFDA conducts product specific pre-approval inspection at Lupin’s Aurangabad facility
Lupin will address the observations and respond to the U.S. FDA within the stipulated timeframe
Lupin will address the observations and respond to the U.S. FDA within the stipulated timeframe
The Formulation & Technology Centre intends to function as a technology storefront, offering advanced formulation and processing solutions to address the growing demand for complex drug formulations
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
Lupin updates on shipment of Mirabegron ER Tablets
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
The cash consideration for the above acquisition will be Euro 26 million.
Arformoterol Tartrate Inhalation Solution is for treatment of bronchoconstriction
The company recently incorporated a new entity in the name of Lupin Digital Health Limited
It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021
Subscribe To Our Newsletter & Stay Updated
